Bradley Foster & Sargent’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2M Sell
38,242
-157,998
-81% -$9.48M 0.03% 222
2025
Q4
$11.5M Buy
196,240
+192,440
+5,064% +$11.7M 0.17% 104
2025
Q3
$211K Buy
+3,800
New +$204K ﹤0.01% 525
2025
Q2
Sell
-9,999
Closed -$586K 554
2025
Q1
$586K Sell
9,999
-800
-7% -$54.2K 0.01% 329
2024
Q4
$778K Buy
10,799
+160
+2% +$11.7K 0.01% 308
2024
Q3
$850K Hold
10,639
0.01% 302
2024
Q2
$762K Sell
10,639
-1,600
-13% -$118K 0.01% 303
2024
Q1
$862K Sell
12,239
-24,933
-67% -$1.78M 0.02% 286
2023
Q4
$2.87M Buy
37,172
+22,024
+145% +$1.45M 0.06% 173
2023
Q3
$1.24M Hold
15,148
0.03% 253
2023
Q2
$1.24M Sell
15,148
-940
-6% -$75.6K 0.03% 253
2023
Q1
$1.19M Sell
16,088
-332
-2% -$25.6K 0.03% 232
2022
Q4
$1.36M Sell
16,420
-864
-5% -$68.6K 0.03% 217
2022
Q3
$1.23M Buy
17,284
+336
+2% +$29K 0.03% 207
2022
Q2
$1.47M Buy
16,948
+800
+5% +$75K 0.04% 203
2022
Q1
$1.75M Buy
16,148
+100
+0.6% +$10.3K 0.04% 213
2021
Q4
$2.08M Sell
16,048
-39,516
-71% -$4.84M 0.04% 199
2021
Q3
$6.73M Sell
55,564
-2,584
-4% -$314K 0.16% 105
2021
Q2
$6.54M Sell
58,148
-48,764
-46% -$5.13M 0.15% 108
2021
Q1
$10.2M Sell
106,912
-180
-0.2% -$16.4K 0.26% 84
2020
Q4
$8.5M Sell
107,092
-272
-0.3% -$19.7K 0.22% 88
2020
Q3
$6.65M Buy
+107,364
New +$6.98M 0.19% 91
2020
Q1
$7.38M Sell
155,672
-12,156
-7% -$608K 0.3% 77
2019
Q4
$9.21M Buy
167,828
+160
+0.1% +$8.39K 0.28% 81
2019
Q3
$8.2M Buy
167,668
+512
+0.3% +$25.7K 0.27% 83
2019
Q2
$8.71M Sell
167,156
-3,360
-2% -$169K 0.29% 79
2019
Q1
$8.46M Buy
170,516
+149,856
+725% +$6.74M 0.3% 77
2018
Q4
$747K Buy
+20,660
New +$863K 0.03% 222

Other funds holding TECH

Bradley Foster & Sargent's TECH Position: Q1 2026 in Review

Bradley Foster & Sargent reduced its Bio-Techne (TECH) stake by 81% in Q1 2026, selling an estimated $9.48M and leaving 38,242 shares worth $2M. The position accounts for 0.03% of the portfolio, ranked #222.

Bradley Foster & Sargent first reported a position in TECH in Q4 2018 and has held it in 28 quarters since. The position peaked at $11.5M in Q4 2025. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Bradley Foster & Sargent held 38,242 shares of Bio-Techne worth $2M as of Q1 2026.
  • Bradley Foster & Sargent sold 157,998 Bio-Techne shares in Q1 2026, an estimated $9.48M.
  • Bio-Techne made up 0.03% of Bradley Foster & Sargent's portfolio in Q1 2026, its #222 holding.
  • Bradley Foster & Sargent first reported a position in Bio-Techne in Q4 2018 and has held it in 28 quarters since.
  • Bradley Foster & Sargent's Bio-Techne position peaked at $11.5M in Q4 2025.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Bradley Foster & Sargent's 13F filing for Q1 2026, filed 15 May 2026.